4.7 Article

Prevention of Mortality and Pneumonia Among Nursing Home Older Adults by Dual Pneumococcal and Seasonal Influenza Vaccination During a Pandemic Caused by Novel Pandemic Influenza A (H1N1)

期刊

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jamda.2012.05.009

关键词

Vaccination; pneumococcus; influenza; pandemic influenza A H1N1; efficacy; nursing home older adults

向作者/读者索取更多资源

Objective: To evaluate the efficacy of dual vaccination of seasonal influenza and pneumococcus in nursing home older adults during a novel pandemic of influenza A (H1N1). Setting: Nine nursing homes in Hong Kong. Participants: A total of 532 nursing home older adults were included in the study. Measurements: Efficacy of dual vaccination of seasonal influenza and pneumococcus in nursing home older adults during a novel pandemic influenza A (H1N1). Design: A prospective 12-month cohort study was conducted on older residents from December 2009 to November 2010. Participants were divided into 3 groups according to their choice of vaccination: received both seasonal influenza and 23-valent pneumococcal polysaccharide vaccine (PPV-TIV group), received seasonal influenza vaccine alone (TIV group), and those who refused both vaccinations (unvaccinated group). Those who had received vaccination for influenza A (H1N1) were excluded. Outcome measures included mortality from all causes, pneumonia, and vascular causes. Results: There were 246 in the PPV-TIV group, 211 in the TIV group, and 75 in the unvaccinated group. Baseline characteristics were similar among the groups. The 12-month mortality rates of the PPV-TIV, TIV alone group, and unvaccinated group were 17.1%, 27.0%, and 37.3% respectively (P < .001). Multivariate analysis demonstrated that, compared with vaccination of seasonal influenza alone, dual vaccination significantly reduced all-cause mortality (hazard ratio [HR] 0.54; 95% confidence interval [CI]: 0.35-0.84; P < .01), mortality from pneumonia (HR 0.60; 95% CI: 0.35-0.99; P < .05), and mortality from vascular causes (HR 0.24; 95% CI: 0.09-0.64; P < .01). Conclusions: During an influenza pandemic or when the circulating influenza strain was not matched by the trivalent seasonal influenza vaccine, dual vaccination of influenza and pneumococcus provided additional protection to nursing home older adults in reducing mortality. Copyright (C) 2012 - American Medical Directors Association, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients

Lu Lu, Bobo Wing-Yee Mok, Lin-Lei Chen, Jacky Man-Chun Chan, Owen Tak-Yin Tsang, Bosco Hoi-Shiu Lam, Vivien Wai-Man Chuang, Allen Wing-Ho Chu, Wan-Mui Chan, Jonathan Daniel Ip, Brian Pui-Chun Chan, Ruiqi Zhang, Cyril Chik-Yan Yip, Vincent Chi-Chung Cheng, Kwok-Hung Chan, Dong-Yan Jin, Ivan Fan-Ngai Hung, Kwok-Yung Yuen, Honglin Chen, Kelvin Kai-Wang To

Summary: Immune sera from BNT162b2 and Coronavac recipients showed reduced neutralizing antibody titers against the omicron variant. The presence of the spike R346K mutation did not affect the neutralization susceptibility.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination With BNT162b2 Increased Risk of Bell's Palsy: A Nested Case-Control and Self-Controlled Case Series Study

Eric Yuk Fai Wan, Celine Sze Ling Chui, Vanessa Wai Sei Ng, Yuan Wang, Vincent Ka Chun Yan, Ivan Chun Hang Lam, Min Fan, Francisco Tsz Tsun Lai, Esther Wai Yin Chan, Xue Li, Carlos King Ho Wong, Raccoon Ka Cheong Chung, Benjamin John Cowling, Wing Chi Fong, Alexander Yuk Lun Lau, Vincent Chung Tong Mok, Frank Ling Fung Chan, Cheuk Kwong Lee, Lot Sze Tao Chan, Dawin Lo, Kui Kai Lau, Ivan Fan Ngai Hung, Chak Sing Lau, Gabriel Matthew Leung, Ian Chi Kei Wong

Summary: Based on electronic health records in Hong Kong, the risk of Bell's palsy increased following BNT162b2 vaccination, particularly within 14 days after the second dose. However, the absolute risk remains very low, so the benefits of COVID-19 vaccination still outweigh the small risk of Bell's palsy.

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial

Anthony Raymond Tam, Ricky Ruiqi Zhang, Kwok Cheung Lung, Raymond Liu, Ka Yi Leung, Danlei Liu, Yujing Fan, Lu Lu, Athene Hoi Ying Lam, Tom Wai Hin Chung, Cyril Chik Yan Yip, Jenny Lo, Alan Ka Lun Wu, Rodney Lee, Simon Sin, Pauline Yeung Ng, Wai Ming Chan, Hoi Ping Shum, Wing Wa Yan, Jasper Fuk Woo Chan, Vincent Chi Chung Cheng, Chak Sing Lau, Kelvin Kai-Wang, Kwok Hung Chan, Kwok Yung Yuen, Ivan Fan Ngai Hung

Summary: Combined treatment with interferon beta-1b and remdesivir is more effective than remdesivir alone in the treatment of COVID-19, providing relief for symptoms, reducing viral shedding and hospitalization time, and inducing earlier antibody response in high-risk patients.

CLINICAL INFECTIOUS DISEASES (2023)

Article Public, Environmental & Occupational Health

Air dispersal of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Implications for hospital infection control during the fifth wave of coronavirus disease 2019 (COVID-19) due to the SARS-CoV-2 omicron variant in Hong Kong

Shuk-Ching Wong, Veronica Wing-Man Chan, Lithia Lai-Ha Yuen, Christine Ho-Yan Auyeung, Jessica Oi-Yan Leung, Chi-Kuen Li, Monica Oi-Tung Kwok, Simon Yung-Chun So, Jonathan Hon-Kwan Chen, Anthony Raymond Tam, Ivan Fan-Ngai Hung, Kelvin Kai-Wang To, Janice Yee-Chi Lo, Kwok-Yung Yuen, Vincent Chi-Chung Cheng

Summary: Despite enhanced indoor air dilution, SARS-CoV-2 RNA was detected in 79.2% of the samples obtained from 8 negative-pressure wards in Hong Kong, indicating the difficulty of preventing airborne transmission of the virus in hospitals.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Article Immunology

Correlations of Myeloperoxidase (MPO), Adenosine deaminase (ADA), C-C motif chemokine 22 (CCL22), Tumour necrosis factor alpha (TNFα) and Interleukin-6 (IL-6) mRNA expression in the nasopharyngeal specimens with the diagnosis and severity of SARS-CoV-2 infections

Kelvin Hei-Yeung Chiu, Cyril Chik-Yan Yip, Rosana Wing-Shan Poon, Kit-Hang Leung, Xin Li, Ivan Fan-Ngai Hung, Kelvin Kai-Wang To, Vincent Chi-Chung Cheng, Kwok-Yung Yuen

Summary: Cytokine dynamics in respiratory specimens of COVID-19 patients were studied in this retrospective case-control study. The study found that levels of MPO, ADA, CCL22, TNF alpha, and IL-6 mRNA were significantly higher in infected patients compared to controls, with ADA showing better performance. Additionally, severe COVID-19 patients had lower CCL22 mRNA levels. ADA may be a better biomarker for differentiating between infected and uninfected patients, while CCL22 has potential in stratifying the severity of COVID-19.

EMERGING MICROBES & INFECTIONS (2023)

Letter Immunology

The first case of monkeypox in Hong Kong presenting as infectious mononucleosis-like syndrome

Kelvin Hei-Yeung Chiu, Shuk-Ching Wong, Anthony Raymond Tam, Siddharth Sridhar, Cyril Chik-Yan Yip, Kwok-Hung Chan, Nicholas Foo-Siong Chew, Kenyon Ka-Yun Man, Wan-Mui Chan, Jonathan Daniel Ip, Allen Wing-Ho Chu, Janice Yee-Chi Lo, Ivan Fan-Ngai Hung, Kwok-Yung Yuen, Kelvin Kai-Wang To, Vincent Chi-Chung Cheng

EMERGING MICROBES & INFECTIONS (2023)

Article Medicine, General & Internal

Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study

Carol Ho-Yan Fong, Xiaojuan Zhang, Lin-Lei Chen, Rosana Wing-Shan Poon, Brian Pui-Chun Chan, Yan Zhao, Carlos King-Ho Wong, Kwok-Hung Chan, Kwok-Yung Yuen, Ivan Fan-Ngai Hung, Jacqueline Kwan Yuk Yuen, Kelvin Kai-Wang To

Summary: This study examined the effects of SARS-CoV-2 infection and vaccine regimens on vaccine-elicited immunity among adults aged >= 70 years in Hong Kong. The results showed that booster doses enhance immunity in individuals with prior infection, while mRNA vaccine boosters enhance T cell response in non-infected individuals. These findings support the use of booster doses for older adults and the use of mRNA vaccine boosters for non-infected individuals.

EBIOMEDICINE (2023)

Article Medicine, General & Internal

Epidemiology and Outcomes of Hypernatraemia in Patients with COVID-19-A Territory-Wide Study in Hong Kong

Benjamin Y. F. So, Chun Ka Wong, Gordon Chun Kau Chan, Jack Kit Chung Ng, Grace Chung Yan Lui, Cheuk Chun Szeto, Ivan Fan Ngai Hung, Hung Fat Tse, Sydney C. W. Tang, Tak Mao Chan, Kai Ming Chow, Desmond Y. H. Yap

Summary: Hypernatraemia is common in COVID-19 patients, especially during the Omicron era. Patients with hypernatraemia have higher 30-day mortality and longer hospital stays. This study provides insights into the epidemiology and clinical outcomes of hypernatraemia in COVID-19 patients.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medicine, General & Internal

Epidemiology and outcomes of hyponatremia in patients with COVID-19-A territory-wide study in Hong Kong

Gordon Chun Kau Chan, Chun Ka Wong, Benjamin Y. F. So, Jack Kit Chung Ng, Grace Chung Yan Lui, Cheuk Chun Szeto, Ivan Fan Ngai Hung, Hung Fat Tse, Sydney C. W. Tang, Tak Mao Chan, Kai Ming Chow, Desmond Y. H. Yap

Summary: This study investigates the epidemiology and outcomes of COVID-19 patients with hyponatremia. The results show that hyponatremic patients have higher 30-day mortality, prolonged hospitalization, and increased ICU admissions. Hyponatremia may serve as a prognostic indicator for unfavorable outcomes in COVID-19.

FRONTIERS IN MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study

Xuxiao Ye, Caige Huang, Vincent Ka Chun Yan, Wei Kang, Min Fan, Gigi Kwan Chi Tsang, Clarissa Mung Yee Ho, Gregory Y. H. Lip, Kai-Hang Yiu, Hung-Fat Tse, Tiantian Ma, Xiwen Qin, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Carlos King Ho Wong, Eric Yuk Fai Wan, Xue Li, Cheuk Kwong Lee, Ivan Fan Ngai Hung, Ian Chi Kei Wong, Esther Wai Yin Chan

Summary: This study aimed to evaluate the risk of ischaemic stroke or systemic embolism and bleeding following COVID-19 vaccination in patients with atrial fibrillation (AF), with a focus on sex differences. The results showed that there was an increased risk of ischaemic stroke or systemic embolism in female patients with AF after receiving the first dose of BNT162b2 or CoronaVac. However, the risk was even higher after COVID-19 infection.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2023)

Article Immunology

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults

Ruiqi Zhang, Kwok-Hung Chan, Pui Wang, Runhong Zhou, Henry Kwong-Chi Yau, Creany Ka-Wai Wong, Meena Wai-Lam Au, Anthony Raymond Tam, Chi-Tao Ng, Matthew Kwok-Chung Lou, Na Liu, Haode Huang, Shaofeng Deng, Rachel Chun-Yee Tam, Ying Liu, Teng Long, Hoi-Wah Tsoi, Miko K. W. Ng, Jian-Piao Cai, Kelvin Kai-Wang To, Man-Fung Yuen, Zhiwei Chen, Honglin Chen, Kwok-Yung Yuen, Ivan Fan-Ngai Hung

Summary: An intranasal COVID-19 vaccine, DelNS1-based RBD vaccines composed of H1N1 subtype (DelNS1-nCoV-RBD LAIV) was developed and tested for safety and immunogenicity in healthy adults. The study recruited 29 participants who were randomly assigned to receive the low or high dose vaccine or a placebo. The vaccine showed moderate mucosal immunogenicity and was well-tolerated, indicating the need for further clinical trials.

VACCINES (2023)

Article Immunology

Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 Recipients

Ka Shing Cheung, Lok Ka Lam, Xianhua Mao, Jing Tong Tan, Poh Hwa Ooi, Ruiqi Zhang, Kwok Hung Chan, Ivan F. N. Hung, Wai Kay Seto, Man Fung Yuen

Summary: The study aimed to investigate the impact of non-alcoholic fatty liver disease (NAFLD) on the immunogenicity of the BNT162b2 vaccine against wild-type and variant strains of SARS-CoV-2, as well as infection outcome. The results showed that NAFLD patients who received two doses of the BNT162b2 vaccine had good immunogenicity against wild-type and delta variant strains, but poor immunogenicity against the omicron variant, and they were not at a higher risk of infection compared to the control group.

VACCINES (2023)

Article Microbiology

Usefulness of Next-Generation Sequencing in Excluding Bovine Leukemia Virus as a Cause of Adult Camel Leukosis in Dromedaries

Ulrich Wernery, Jade L. L. Teng, Yuanchao Ma, Joerg Kinne, Man-Lung Yeung, Safna Anas, Susanna K. P. Lau, Patrick C. Y. Woo

Summary: This study used next-generation sequencing (NGS) to detect all possible viruses in five lung samples from five dromedaries with histopathological evidence of adult camel leukosis and four tissue samples from two control dromedaries. The results showed that no bovine leukemia virus (BLV) or its genetic variants or any other virus was detected in the nine tissue samples.

PATHOGENS (2023)

Article Neurosciences

A Pilot Study of Short-Course Oral Vitamin A and Aerosolised Diffuser Olfactory Training for the Treatment of Smell Loss in Long COVID

Tom Wai-Hin Chung, Hui Zhang, Fergus Kai-Chuen Wong, Siddharth Sridhar, Tatia Mei-Chun Lee, Gilberto Ka-Kit Leung, Koon-Ho Chan, Kui-Kai Lau, Anthony Raymond Tam, Deborah Tip-Yin Ho, Vincent Chi-Chung Cheng, Kwok-Yung Yuen, Ivan Fan-Ngai Hung, Henry Ka-Fung Mak

Summary: This pilot trial recruited long COVID patients with persistent olfactory dysfunction and found that a combination treatment of oral vitamin A and olfactory training was effective in improving olfactory function.

BRAIN SCIENCES (2023)

Article Endocrinology & Metabolism

A prospective follow-up on thyroid function, thyroid autoimmunity and long COVID among 250 COVID-19 survivors

David Tak Wai Lui, Kimberly Hang Tsoi, Chi Ho Lee, Chloe Yu Yan Cheung, Carol Ho Yi Fong, Alan Chun Hong Lee, Anthony Raymond Tam, Polly Pang, Tip Yin Ho, Chun Yiu Law, Ching Wan Lam, Kelvin Kai Wang To, Wing Sun Chow, Yu Cho Woo, Ivan Fan Ngai Hung, Kathryn Choon Beng Tan, Karen Siu Ling Lam

Summary: This study evaluated the evolution of thyroid function and autoimmunity among COVID-19 survivors over 6 months. The results showed that most abnormal thyroid function in acute COVID-19 resolved within 6 months, and SARS-CoV-2 infection did not lead to change in thyroid autoimmunity. Interferon treatment was associated with a modest increase in anti-thyroid antibody titres. Thyroid function and anti-thyroid antibodies did not play a significant role in long COVID.

ENDOCRINE (2023)

暂无数据